{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:24:59Z","timestamp":1793247899660,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA042852"],"award-info":[{"award-number":["R01 DA042852"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 NS098772"],"award-info":[{"award-number":["R01 NS098772"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 NS120663"],"award-info":[{"award-number":["R01 NS120663"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R41 DA050364"],"award-info":[{"award-number":["R41 DA050364"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R41 NS116784-01"],"award-info":[{"award-number":["R41 NS116784-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.trsl.2021.01.002","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:13:47Z","timestamp":1610237627000},"page":"20-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Targeting T-type\/CaV3.2 channels for chronic pain"],"prefix":"10.1016","volume":"234","author":[{"given":"Song","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubin","family":"Moutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2021.01.002_bib0001","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1074\/jbc.M111.290882","article-title":"A Ca(v)3.2\/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis","volume":"287","author":"Weiss","year":"2012","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.trsl.2021.01.002_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2001.013269","article-title":"Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability","volume":"540","author":"Chemin","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0003","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1523\/JNEUROSCI.19-06-01912.1999","article-title":"Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family","volume":"19","author":"Lee","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0004","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/36110","article-title":"Molecular characterization of a neuronal low-voltage-activated T-type calcium channel","volume":"391","author":"Perez-Reyes","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2021.01.002_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.trsl.2021.01.002_bib0006","doi-asserted-by":"crossref","first-page":"13705","DOI":"10.1073\/pnas.1511740112","article-title":"Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties","volume":"112","author":"Blesneac","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2021.01.002_bib0007","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1476-5381.2011.01256.x","article-title":"T-type voltage-gated calcium channels as targets for the development of novel pain therapies","volume":"163","author":"Todorovic","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1523\/JNEUROSCI.4305-09.2010","article-title":"Selective T-type calcium channel block in thalamic neurons reveals channel redundancy and physiological impact of I(T)window","volume":"30","author":"Dreyfus","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0009","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/chan.4.6.14106","article-title":"Contributions of T-type calcium channel isoforms to neuronal firing","volume":"4","author":"Cain","year":"2010","journal-title":"Channels"},{"key":"10.1016\/j.trsl.2021.01.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108187","article-title":"Functional expression of T-type Ca2+ channels in spinal motoneurons of the adult turtle","volume":"9","author":"Canto-Bustos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2021.01.002_bib0011","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4161\/chan.4.6.12889","article-title":"Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels","volume":"4","author":"Perez-Reyes","year":"2010","journal-title":"Channels"},{"key":"10.1016\/j.trsl.2021.01.002_bib0012","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00424-014-1449-7","article-title":"Cav3 T-type channels: regulators for gating, membrane expression, and cation selectivity","volume":"466","author":"Senatore","year":"2014","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0013","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1046\/j.1460-9568.1999.00849.x","article-title":"Comparison of the Ca2\u202f+\u202fcurrents induced by expression of three cloned alpha1 subunits, alpha1G, alpha1H and alpha1I, of low-voltage-activated T-type Ca2\u202f+\u202fchannels","volume":"11","author":"Klockner","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0014","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/3669","article-title":"Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin","volume":"1","author":"Chuang","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0006-291X(02)02706-7","article-title":"Two new scorpion toxins that target voltage-gated Ca2+ and Na+ channels","volume":"299","author":"Olamendi-Portugal","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2021.01.002_bib0016","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1523\/JNEUROSCI.22-06-02023.2002","article-title":"Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels","volume":"22","author":"Sidach","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0017","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ana.410250610","article-title":"Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons","volume":"25","author":"Coulter","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1126\/science.2451291","article-title":"Amiloride selectively blocks the low threshold (T) calcium channel","volume":"240","author":"Tang","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.trsl.2021.01.002_bib0019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.aao2300","article-title":"CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage","volume":"360","author":"Abe","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.trsl.2021.01.002_bib0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1023\/A:1007706022381","article-title":"T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance","volume":"11","author":"Ertel","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.trsl.2021.01.002_bib0021","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/mol.54.6.1080","article-title":"Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons","volume":"54","author":"McDonough","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0022","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1152\/jn.1998.79.1.240","article-title":"Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents","volume":"79","author":"Todorovic","year":"1998","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0023","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00005344-198913050-00011","article-title":"In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action","volume":"13","author":"Osterrieder","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0024","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.RES.75.1.144","article-title":"Selective inhibition of T-type Ca2+ channels by Ro 40-5967","volume":"75","author":"Mishra","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2021.01.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(97)00569-9","article-title":"Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist","volume":"80","author":"Kobrin","year":"1997","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2021.01.002_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000047276","article-title":"Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist","volume":"89","author":"Kobrin","year":"1998","journal-title":"Cardiology"},{"key":"10.1016\/j.trsl.2021.01.002_bib0027","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(05)78800-0","article-title":"What lessons can be learnt from withdrawal of mibefradil from the market?","volume":"351","author":"Po","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2021.01.002_bib0028","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/S0006-3495(99)77134-1","article-title":"Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H","volume":"77","author":"Lee","year":"1999","journal-title":"Biophys J"},{"key":"10.1016\/j.trsl.2021.01.002_bib0029","doi-asserted-by":"crossref","first-page":"12577","DOI":"10.1523\/JNEUROSCI.2206-07.2007","article-title":"Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate","volume":"27","author":"Nelson","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0030","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1523\/JNEUROSCI.1800-07.2007","article-title":"Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels","volume":"27","author":"Nelson","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0031","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0026-895X(24)12624-7","article-title":"Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide","volume":"60","author":"Todorovic","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0032","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.104.002402","article-title":"5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo","volume":"66","author":"Todorovic","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0033","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/mol.111.073205","article-title":"TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent","volume":"80","author":"Choe","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0034","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.110.171058","article-title":"In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice","volume":"335","author":"Kraus","year":"2010","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"Suppl 2","key":"10.1016\/j.trsl.2021.01.002_bib0035","first-page":"S11","article-title":"Z944: a first in class T-type calcium channel modulator for the treatment of pain","volume":"19","author":"Lee","year":"2014","journal-title":"J Peripheral Nerv Syst: JPNS"},{"key":"10.1016\/j.trsl.2021.01.002_bib0036","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1523\/JNEUROSCI.0517-20.2020","article-title":"Contribution of T-type calcium channels to spinal cord injury-induced hyperexcitability of nociceptors","volume":"40","author":"Lauzadis","year":"2020","journal-title":"J Neurosci"},{"issue":"545","key":"10.1016\/j.trsl.2021.01.002_bib0037","doi-asserted-by":"crossref","first-page":"eaao4425","DOI":"10.1126\/scisignal.aao4425","article-title":"Selective inhibition of Ca(V)3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain","volume":"11","author":"Joksimovic","year":"2018","journal-title":"Sci Signal"},{"key":"10.1016\/j.trsl.2021.01.002_bib0038","doi-asserted-by":"crossref","first-page":"8766","DOI":"10.1523\/JNEUROSCI.2527-05.2005","article-title":"The endogenous redox agent L-cysteine induces T-type Ca2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors","volume":"25","author":"Nelson","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127572","article-title":"Expression and regulation of Cav3.2 T-type calcium channels during inflammatory hyperalgesia in mouse dorsal root ganglion neurons","volume":"10","author":"Watanabe","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2021.01.002_bib0040","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1523\/JNEUROSCI.19-06-01895.1999","article-title":"Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels","volume":"19","author":"Talley","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0041","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1523\/JNEUROSCI.0068-12.2012","article-title":"Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons","volume":"32","author":"Jacus","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0042","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.celrep.2014.12.042","article-title":"The low-threshold calcium channel Cav3.2 determines low-threshold mechanoreceptor function","volume":"10","author":"Francois","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2021.01.002_bib0043","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.emboj.7600515","article-title":"Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception","volume":"24","author":"Bourinet","year":"2005","journal-title":"The EMBO J"},{"key":"10.1016\/j.trsl.2021.01.002_bib0044","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000276981","article-title":"The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia","volume":"85","author":"Wen","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.trsl.2021.01.002_bib0045","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1152\/jn.01031.2007","article-title":"Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve","volume":"99","author":"Jagodic","year":"2008","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0046","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aev198","article-title":"Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats","volume":"115","author":"Chen","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.trsl.2021.01.002_bib0047","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.aat.2016.09.001","article-title":"Chronic intrathecal infusion of T-type calcium channel blockers attenuates CaV3.2 upregulation in nerve-ligated rats","volume":"54","author":"Shiue","year":"2016","journal-title":"Acta anaesthesiologica Taiwanica"},{"key":"10.1016\/j.trsl.2021.01.002_bib0048","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1523\/JNEUROSCI.0181-19.2019","article-title":"Cdk5-dependent phosphorylation of CaV3.2 T-type channels: possible role in nerve ligation-induced neuropathic allodynia and the compound action potential in primary afferent C fibers","volume":"40","author":"Gomez","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0049","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919836569","article-title":"Nerve injury elevates functional Cav3.2 channels in superficial spinal dorsal horn","volume":"15","author":"Feng","year":"2019","journal-title":"Mol Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pain.2010.04.022","article-title":"Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain","volume":"150","author":"Takahashi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918765808","article-title":"Increased expression of CaV3.2 T-type calcium channels in damaged DRG neurons contributes to neuropathic pain in rats with spared nerve injury","volume":"14","author":"Kang","year":"2018","journal-title":"Mol Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0052","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/BRS.0b013e318272fbf8","article-title":"Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury","volume":"38","author":"Yue","year":"2013","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.trsl.2021.01.002_bib0053","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/j.pain.0000000000000774","article-title":"Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy","volume":"158","author":"Li","year":"2017","journal-title":"Pain."},{"key":"10.1016\/j.trsl.2021.01.002_bib0054","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pain.2009.06.012","article-title":"In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy","volume":"145","author":"Messinger","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0055","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1523\/JNEUROSCI.4866-06.2007","article-title":"Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons","volume":"27","author":"Jagodic","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0056","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/WNR.0000000000000607","article-title":"Colocalization of insulin-like growth factor-1 receptor and T type Cav3.2 channel in dorsal root ganglia in chronic inflammatory pain mouse model","volume":"27","author":"Lin","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.trsl.2021.01.002_bib0057","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1073\/pnas.1100869108","article-title":"T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome","volume":"108","author":"Marger","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2021.01.002_bib0058","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tox.2017.11.012","article-title":"Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Cav3.2 in mice","volume":"393","author":"Ozaki","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.trsl.2021.01.002_bib0059","doi-asserted-by":"crossref","DOI":"10.1177\/1744806920963807","article-title":"Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis","volume":"16","author":"Shin","year":"2020","journal-title":"Mol Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnmol.2018.00024","article-title":"Accumulation of Cav3.2 T-type calcium channels in the uninjured sural nerve contributes to neuropathic pain in rats with spared nerve injury","volume":"11","author":"Chen","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0061","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neures.2018.04.002","article-title":"Upregulation of Cav3.2 T-type calcium channels in adjacent intact L4 dorsal root ganglion neurons in neuropathic pain rats with L5 spinal nerve ligation","volume":"142","author":"Liu","year":"2019","journal-title":"Neurosci Res"},{"key":"10.1016\/j.trsl.2021.01.002_bib0062","first-page":"605","article-title":"A role for uninjured afferents in neuropathic pain","volume":"60","author":"Meyer","year":"2008","journal-title":"Sheng li xue bao: [Acta physiologica Sinica]"},{"key":"10.1016\/j.trsl.2021.01.002_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173587","article-title":"Ca(v)3.2 overexpression in L4 dorsal root ganglion neurons after L5 spinal nerve cutting involves Egr-1, USP5 and HMGB1 in rats: An emerging signaling pathway for neuropathic pain","author":"Tomita","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0064","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity","volume":"83","author":"Garcia-Caballero","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.trsl.2021.01.002_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12990-015-0011-8","article-title":"Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain","volume":"11","author":"Gadotti","year":"2015","journal-title":"Mol Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0066","first-page":"12","article-title":"A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain","author":"Garcia-Caballero","year":"2016","journal-title":"Mol Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0067","first-page":"19","article-title":"Prevention and treatment of chemotherapy-induced peripheral neuropathy. American journal of health-system pharmacy","volume":"71","author":"Piccolo","year":"2014","journal-title":"AJHP"},{"key":"10.1016\/j.trsl.2021.01.002_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"Staff","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0069","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1523\/JNEUROSCI.18-21-08605.1998","article-title":"Low-voltage-activated Ca2+ currents are generated by members of the CavT subunit family (alpha1G\/H) in rat primary sensory neurons","volume":"18","author":"Lambert","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0070","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/j.pain.0000000000001955","article-title":"A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies","volume":"161","author":"Cai","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0071","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/j.pain.0000000000001385","article-title":"Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels","volume":"160","author":"Bellampalli","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0072","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2021.01.002_bib0073","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1526-4637.2007.00347.x","article-title":"Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options","volume":"9","author":"Veves","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.trsl.2021.01.002_bib0074","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12990-015-0028-z","article-title":"Upregulation of T-type Ca2+ channels in long-term diabetes determines increased excitability of a specific type of capsaicin-insensitive DRG neurons","volume":"11","author":"Duzhyy","year":"2015","journal-title":"Mol Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0075","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bbadis.2013.01.017","article-title":"Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy","volume":"1832","author":"Khomula","year":"2013","journal-title":"Biochimica et biophysica acta"},{"issue":"Pt 2","key":"10.1016\/j.trsl.2021.01.002_bib0076","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1113\/jphysiol.1995.sp020814","article-title":"Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the Bio Bred\/Worchester diabetic rat","volume":"486","author":"Hall","year":"1995","journal-title":"J Physiol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0077","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.2337\/db13-0813","article-title":"Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels","volume":"62","author":"Orestes","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.01.002_bib0078","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00424-013-1259-3","article-title":"Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation","volume":"465","author":"Weiss","year":"2013","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0079","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.2337\/db08-1763","article-title":"Selective T-type calcium channel blockade alleviates hyperalgesia in ob\/ob mice","volume":"58","author":"Latham","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.01.002_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","article-title":"Hyperhomocysteinemia and neurologic disorders: a review","volume":"10","author":"Ansari","year":"2014","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0081","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1097\/j.pain.0000000000001669","article-title":"A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy","volume":"160","author":"Gaifullina","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0082","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1601-183X.2006.00268.x","article-title":"Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels","volume":"6","author":"Choi","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.trsl.2021.01.002_bib0083","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/bph.14608","article-title":"Inhibition of Cav 3.2 calcium channels: a new target for colonic hypersensitivity associated with low-grade inflammation","volume":"176","author":"Picard","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0084","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuroscience.2011.02.044","article-title":"Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels","volume":"181","author":"Matsunami","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.trsl.2021.01.002_bib0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1476-5381.2012.02060.x","article-title":"Involvement of the endogenous hydrogen sulfide\/Ca(v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice","volume":"167","author":"Matsunami","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0086","doi-asserted-by":"crossref","first-page":"ra94","DOI":"10.1126\/scisignal.2005283","article-title":"Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci Signal"},{"key":"10.1016\/j.trsl.2021.01.002_bib0087","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1074\/jbc.M109.067660","article-title":"Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels","volume":"285","author":"Kang","year":"2010","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.trsl.2021.01.002_bib0088","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1074\/jbc.M510197200","article-title":"A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels","volume":"281","author":"Kang","year":"2006","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.trsl.2021.01.002_bib0089","doi-asserted-by":"crossref","first-page":"15489","DOI":"10.1074\/jbc.M111.310763","article-title":"Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST)","volume":"287","author":"van Loo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.01.002_bib0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13041-019-0493-9","article-title":"SUMOylation regulates USP5-Cav3.2 calcium channel interactions","volume":"12","author":"Garcia-Caballero","year":"2019","journal-title":"Mol Brain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0091","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917724698","article-title":"Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway","volume":"13","author":"Stemkowski","year":"2017","journal-title":"Mol Pain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0092","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13041-018-0405-4","article-title":"Disrupting USP5\/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation","volume":"11","author":"Gadotti","year":"2018","journal-title":"Mol Brain"},{"key":"10.1016\/j.trsl.2021.01.002_bib0093","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2008.10.004","article-title":"Regulation of neuronal T-type calcium channels","volume":"30","author":"Iftinca","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2021.01.002_bib0094","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.bbamem.2012.08.032","article-title":"Modulation of low-voltage-activated T-type Ca(2)(+) channels","volume":"1828","author":"Zhang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2021.01.002_bib0095","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bbamem.2017.01.018","article-title":"Glycosylation of voltage-gated calcium channels in health and disease","volume":"1859","author":"Lazniewska","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.trsl.2021.01.002_bib0096","doi-asserted-by":"crossref","first-page":"34028","DOI":"10.1074\/jbc.M105248200","article-title":"Glycosylation increases potassium channel stability and surface expression in mammalian cells","volume":"276","author":"Khanna","year":"2001","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.trsl.2021.01.002_bib0097","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/acs.jproteome.5b00733","article-title":"Identification of novel N-glycosylation sites at noncanonical protein consensus motifs","volume":"15","author":"Lowenthal","year":"2016","journal-title":"J Proteome Res"},{"key":"10.1016\/j.trsl.2021.01.002_bib0098","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbpb.2010.01.017","article-title":"N-glycosylation at non-canonical Asn-X-Cys sequence of an insect recombinant cathepsin B-like counter-defense protein","volume":"156","author":"Chi","year":"2010","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.1016\/j.trsl.2021.01.002_bib0099","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13041-020-00697-z","article-title":"Functional identification of potential non-canonical N-glycosylation sites within Cav3.2 T-type calcium channels","volume":"13","author":"Ficelova","year":"2020","journal-title":"Mol Brain"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:45:36Z","timestamp":1761828336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524421000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":99,"alternative-id":["S1931524421000025"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2021.01.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting T-type\/CaV3.2 channels for chronic pain","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2021.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}